Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

R&D Systems™ Rhesus Macaque IL-18/IL-1F4 Recombinant Protein

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.

Supplier:  R&D Systems™ 2548RM025/CF

 View more versions of this product

Catalog No. 2548RM025CF

Add to Cart
This item is not returnable. View return policy



The Recombinant Rhesus Macaque IL-18/IL-1F4 Protein is derived from E. coli. The Recombinant Rhesus Macaque IL-18/IL-1F4 Protein has been validated for the following applications: Bioactivity.


Supplied as a 0.2μm filtered solution in MOPS, Na2SO4, EDTA and DTT.
E. coli-derived rhesus macaque IL-18/IL-1F4 protein Tyr37-Asp193
It is recommended that sterile PBS be added to the vial to prepare a working stock solution of no less than 100 μg/mL. The carrier-free protein should be used immediately upon reconstitution to avoid losses in activity due to non-specific binding to the inside surface of the vial. For long term storage as a dilute solution, a carrier protein (e.g. 0.1% HSA or BSA) should be added to the vial.
18.2 kDa
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 6 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after opening.
97%, by SDS-PAGE under reducing conditions and visualized by silver stain.


Product Certifications


Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit